Innovative implantable bio-artificial pancreas for the treatment of diabetes - Beta-O2 Technologies Beta-O2 is developing an implantable bio-artificial pancreas for the treatment of insulin dependent diabetic patients (Type I diabetes, and a subgroup of Type II diabetes). The device contains islets of Langerhans (containing beta cells - insulin-producing cells), which are continuously oxygenated. The islets sense the glucose levels in the body and secrete the corresponding levels of insulin necessary to maintaining normal glucose levels. Beta-o2.com~Site InfoWhoisTrace RouteRBL Check
